In addition to being a risk factor for breast cancer, breast density has been hypothesized to be a surrogate biomarker for predicting response to endocrine-based chemotherapies. The purpose of this study was to evaluate whether a non-invasive bedside scanner based on diffuse optical spectroscopic imaging (DOSI) provides quantitative metrics to measure and track changes in breast tissue composition and density. In order to access a broad range of densities in a limited patient population, we performed optical measurements on the contralateral normal breast of patients before and during neoadjuvant chemotherapy (NAC). In this work, DOSI parameters, including tissue hemoglobin, water, and lipid concentrations were obtained and correlated with magnetic resonance imaging (MRI)-measured fibroglandular tissue density. We evaluate how DOSI could be used to assess breast density while gaining new insight into the impact of chemotherapy on breast tissue.
»
02/22/13